tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

Compare
30 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$4.97
$126.68M
-4.11
-46.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$3.11
$108.49M
-1.46
-12.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.59
$147.57M
7.08
4.05%
4 Buy
1 Hold
0 Sell
Strong Buy
Nkarta
$2.47
$180.41M
-1.78
5.11%
4 Buy
1 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.14
$207.40M
-1.21
-44.08%
3 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.38
$530.16M
-2.25
134.73%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
4.97
-3.86
-43.71%
AGEN
Agenus
3.11
-0.43
-12.15%
BDTX
Black Diamond Therapeutics
2.57
0.05
1.98%
NKTX
Nkarta
2.47
0.11
4.66%
CCCC
C4 Therapeutics
2.03
-1.65
-44.84%
KYTX
Kyverna Therapeutics, Inc.
8.38
5.07
153.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts